Centessa Pharmaceuticals Announces New Chief People Officer Karen Anderson

Rhea-AI Summary

Centessa Pharmaceuticals (Nasdaq: CNTA) has appointed Karen Anderson as its new Chief People Officer, a role aimed at enhancing the company’s human resources and culture strategy. With over 25 years of experience in HR across biotechnology and pharmaceuticals, Anderson previously served as Chief Human Resources Officer at Mimecast and held senior positions at Alnylam Pharmaceuticals and Pfizer. CEO Saurabh Saha emphasized Anderson's strong track record in building high-performing teams, aligning with Centessa’s mission to develop transformational medicines for patients.

Positive

• Appointment of Karen Anderson as Chief People Officer to enhance HR and culture strategy.
• Anderson's extensive HR experience in biotechnology and pharmaceuticals.
• CEO's confidence in Anderson's ability to build high-performing teams.

Negative

• None.

BOSTON and LONDON, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company focused on discovering and developing medicines that are transformational for patients, today announced Karen Anderson as its new Chief People Officer. In this newly created position, Karen will lead the Company’s human resources function and help define Centessa’s people and culture strategy.

Karen joins Centessa with over 25 years of experience in human resources roles spanning the biotechnology/pharmaceutical, technology and healthcare industries. Prior to joining Centessa, Karen was Chief Human Resources Officer at Mimecast Limited. Previously, she was Senior Vice President and Chief Human Resources Officer at Alnylam Pharmaceuticals where she supported the strategic direction and business growth from a few hundred employees to more than 1,000 employees in 16 global legal entities. Karen was also Vice President of Human Resources at Pfizer, supporting the Commercial business unit in both developed and emerging markets. Earlier in her career she was responsible for compensation, benefits and systems for Bayer Canada before becoming the Global Human Resources Director for Baxter where she had a strong focus on mergers and acquisitions.

“Centessa attracts the industry’s best and brightest people,” said Saurabh Saha MD PhD, Chief Executive Officer of Centessa. “Karen is highly qualified and has a strong track record building and supporting high-performing teams. We are excited to work with her as we continue to drive our strategy forward and build on our agile culture.”

“I believe in the mission at Centessa to develop medicines that can be transformational for patients,” said Karen Anderson. “I look forward to working with this talented team to help nurture the culture and support the company’s ambitious and exciting future.”

About Centessa Pharmaceuticals 
Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients. Our programs span discovery-stage to late-stage development and cover a range of high-value indications. We operate with the conviction that each one of our programs has the potential to change the current treatment paradigm and establish a new standard of care. For more information, visit www.centessa.com, which does not form part of this release.

Contact:
Kristen K. Sheppard, Esq.
SVP of Investor Relations
investors@centessa.com

FAQ

What is the significance of Karen Anderson's appointment at Centessa Pharmaceuticals?

Karen Anderson's appointment as Chief People Officer is significant as she will lead the company's HR function and culture strategy, crucial for supporting its growth.

What experience does Karen Anderson bring to Centessa Pharmaceuticals?

Karen Anderson brings over 25 years of HR experience from the biotechnology and pharmaceutical industries, having held leadership roles at Mimecast, Alnylam Pharmaceuticals, and Pfizer.

How might Karen Anderson's role impact Centessa Pharmaceuticals' future?

Her role could enhance Centessa's talent acquisition, employee engagement, and overall company culture, supporting its strategic goals in drug development.

What is Centessa Pharmaceuticals' mission?

Centessa Pharmaceuticals aims to discover and develop transformational medicines for patients, focusing on high-value indications.

What does the appointment of a Chief People Officer indicate about Centessa Pharmaceuticals?

It indicates that Centessa is prioritizing its human resources and corporate culture as it seeks to scale and improve its organizational effectiveness.